πŸ‡ΊπŸ‡Έ FDA
Patent

US 10464941

Therapeutic compounds

granted A61KA61K31/4545A61K31/485

Quick answer

US patent 10464941 (Therapeutic compounds) held by Regents of the University of Minnesota expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4545, A61K31/485, A61K45/06, A61K47/54